Item 7.01. Regulation FD Disclosure.

On January 5, 2021, OrthoPediatrics Corp. ("the Company") issued a press release announcing the domestic launch of its first sterile-packed implants for the Pediatric Nailing Platform| FEMUR ("PNP|FEMUR"). The PNP|FEMUR system, now available in 4 countries, was designed for use in pediatric and small stature adult patients to address femoral shaft fractures, subtrochanteric femur fractures, ipsilateral neck/shaft fractures, prophylactic nailing of impending pathologic fractures, nonunions, malunions, and fixation of femurs that have been surgically prepared (osteotomy) for correction of deformity. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.

The Company does not intend for this Item 7.01 or Exhibit 99.1 to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.



  (d)   Exhibits
        Exhibit No.         Description
               99.1           Press r    elease dated     January 5, 2021, issued by OrthoPediatrics
                            Corp.
                104         Cover Page Interactive Data File (embedded within the Inline XBRL
                            document).



                                  * * * * * *

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses